54gene.com
Get leads like 54gene — and thousands more
Build targeted lists by tech stack, and more
54gene: The $44M African Genomics Startup That Vanished
A deep dive into the rise, funding, and mysterious disappearance of a biotech pioneer
In 2020, 54gene was Africa's brightest biotech hope, raising $44M to decode the continent's DNA. Today, its website is a parking page. This is the story of a startup that promised to revolutionize global genomics but ended up as a cautionary tale for founders and investors.
"The most valuable genomics startup in Africa had zero traffic when it shut down. That's not just a failure—it's a warning sign."
The Rise: From Lagos to Global Ambition
Founded in 2019, 54gene aimed to solve a massive data problem: only 5% of genomic data comes from non-European populations. With $44.7M in funding from investors like Y Combinator and Cathay Innovation, they built a biobank of 100,000+ African samples. Their promise? To create drugs that work for everyone, not just Western populations. At their peak, they operated labs in Lagos and Washington D.C., partnering with global pharma giants.
The Collapse: When the Lights Went Out
By late 2023, the dream unraveled. Reports emerged of unpaid salaries, lab closures, and executive departures. The final blow? A website that now redirects to a parking page. Zero traffic. Zero updates. Zero presence. For a company with $48.2M in revenue and 249 employees, this isn't just a pivot—it's a full stop. The tech stack (jQuery, Tailwind, PHP) suggests they never even rebuilt their site after the shutdown.
What makes 54gene's story uniquely tragic is the scale of ambition vs. execution. They didn't just build a local lab—they aimed to be the '23andMe of Africa' while simultaneously developing pharmaceuticals. The dual focus on consumer genomics and drug discovery required massive capital and operational excellence, two things that ultimately broke them.
- Raised $44.7M but couldn't scale operations sustainably
- Targeted the underserved African genomics market (1.3B people)
- Built a biobank of 100K+ samples but failed to monetize effectively
- Had global pharma partnerships but collapsed due to internal mismanagement
- Zero digital footprint today despite $48M in revenue
The Genomics Gold Rush Left a Body Count
54gene's story proves that even with $44M and a massive market, execution beats vision every time. For founders: build sustainable revenue before chasing unicorn status. For investors: diligence on operations, not just market size.
What tech stack does 54gene use?
How much traffic does 54gene get?
Traffic & Engagement
How is 54gene's SEO?
Meta Tags
Parking Page
H1 Tags
What is 54gene's revenue?
Who works at 54gene?
Loading leads...
What do customers think of 54gene?
No Trustpilot reviews available for this company.
Frequently Asked Questions about 54gene
What is 54gene's Revenue?
How fast is 54gene growing?
What technologies does 54gene use?
Who are 54gene's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact 54gene?
Contact Information
What are 54gene's key pages?
Export 54gene.com Data
Download the complete tech stack, analytics, leads, and company data for 54gene.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About 54gene.com
Company Overview
54gene.com Key Pages
Contact 54gene.com
Phone Numbers
Technology Stack
54gene.com uses 3 technologies across their website including PHP, Tailwind CSS, jQuery.
Programming Languages
PHP
CSS Frameworks
Tailwind CSS
JavaScript Libraries
jQuery
Traffic & Audience
54gene.com receives approximately 0 monthly visitors. The website has a bounce rate of 0% with visitors viewing an average of 0.0 pages per visit. Users spend an average of 0:00 on the site.
Frequently Asked Questions
What is 54gene.com?
What technologies does 54gene.com use?
How popular is 54gene.com?
Related Searches
This page provides publicly available information about 54gene.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit 54gene.com directly at https://54gene.com.